Bristol-Myers Squibb (BMY)
60.93
0.00 (0.00%)
Upcoming Events
Latest Headlines
Bristol Myers buys Nvidia's latest AI computing system for drug research
July 20, 2026 7:01 AM - StreetInsider
Bristol Myers Squibb expands Nvidia AI infrastructure for drug discovery
July 20, 2026 6:59 AM - StreetInsider
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
July 20, 2026 6:59 AM - BizWire
FDA accepts Bristol Myers Squibb's mezigdomide application for myeloma
July 13, 2026 6:59 AM - StreetInsider
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
July 13, 2026 6:59 AM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: YALE PHYLLIS R
July 2, 2026 4:20 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Samuels Theodore R. II
July 2, 2026 4:18 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Rice Derica W
July 2, 2026 4:18 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: McMullen Michael R.
July 2, 2026 4:17 PM - SEC Filing
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 30 Filed by: Arduini Peter J
July 2, 2026 4:16 PM - SEC Filing
The Quest to Repair What Multiple Sclerosis Takes Away
June 24, 2026 8:30 AM - StreetInsider
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
June 18, 2026 6:59 AM - BizWire
Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4.6% Yield
June 17, 2026 4:16 PM - StreetInsider
Bristol Myers Squibb Announces Dividend
June 17, 2026 4:16 PM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 15 Filed by: Haller Julia A
June 16, 2026 4:08 PM - SEC Filing
Leerink highlights drug demand rebound after Memorial Day
June 12, 2026 2:42 PM - StreetInsider
Bristol-Myers Squibb (BMY) call put ratio 6.8 calls to 1 put with a focus on spreader of 8244 contracts of June and July 57.50 calls
June 11, 2026 2:50 PM - StreetInsider
Mariska Hargitay partners with Bristol Myers Squibb for myeloma awareness
June 8, 2026 7:00 AM - StreetInsider
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
June 8, 2026 6:59 AM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: Jun 03 Filed by: Short Bartie Wendy
June 5, 2026 4:11 PM - SEC Filing
Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31
June 5, 2026 1:46 PM - SEC Filing
Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31
June 5, 2026 1:45 PM - SEC Filing
Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31
June 5, 2026 1:45 PM - SEC Filing
Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial
June 3, 2026 8:01 AM - StreetInsider
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
June 3, 2026 8:00 AM - BizWire
Bristol Myers Squibb drug shows survival benefit in cancer trials
June 2, 2026 8:02 AM - StreetInsider
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Brea
June 2, 2026 8:00 AM - BizWire
FDA accepts Bristol Myers Squibb Camzyos application for adolescent treatment
June 1, 2026 6:59 AM - StreetInsider
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hype
June 1, 2026 6:59 AM - BizWire
Bristol Myers Squibb gains EU approval for Opdivo combination in lymphoma
June 1, 2026 6:56 AM - StreetInsider
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
June 1, 2026 6:55 AM - BizWire
Bristol Myers Squibb drug reduces multiple myeloma progression risk by 52%
May 29, 2026 8:02 AM - StreetInsider
Bristol Myers Squibb Announces CELMoD Mezigdomide Reduces Risk of Disease Progression or Death by More than 50% vs. Standard of Care in Relapsed or Refractory Multiple Myeloma
May 29, 2026 8:00 AM - BizWire
UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
May 28, 2026 10:09 AM - StreetInsider
Bristol Myers Squibb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026 6:59 AM - BizWire
Bristol Myers Squibb to present 60+ oncology studies at ASCO 2026
May 21, 2026 5:01 PM - StreetInsider
Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
May 21, 2026 5:01 PM - BizWire
Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery
May 20, 2026 7:48 AM - StreetInsider
Bristol Myers Squibb partners with Anthropic to deploy AI across operations
May 20, 2026 6:59 AM - StreetInsider
Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations
May 20, 2026 6:59 AM - BizWire
Bristol-Myers Squibb (BMY) brings Anthropic’s Claude to 30,000 of its staff - WSJ
May 20, 2026 6:54 AM - StreetInsider
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience
May 14, 2026 8:30 AM - BizWire
Bernstein SocGen on Bristol-Myers Squibb Co. (BMY): 'Hengrui deal highlights acceleration possibilities in China'
May 13, 2026 8:04 AM - StreetInsider
Pacira BioSciences urges stockholders to support board nominees
May 12, 2026 4:01 PM - StreetInsider
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
May 12, 2026 4:01 PM - StreetInsider
BMO Capital Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)
May 12, 2026 10:34 AM - StreetInsider
Form S-8 BRISTOL MYERS SQUIBB CO
May 8, 2026 4:34 PM - SEC Filing
Form 8-K BRISTOL MYERS SQUIBB CO For: May 05
May 8, 2026 4:12 PM - SEC Filing
Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis
May 8, 2026 7:00 AM - StreetInsider
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults
May 8, 2026 6:59 AM - BizWire
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026
May 6, 2026 6:59 AM - BizWire
Form 4 BRISTOL MYERS SQUIBB CO For: May 01 Filed by: Lenkowsky Adam
May 5, 2026 5:11 PM - SEC Filing
BMO Capital Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)
May 4, 2026 7:29 AM - StreetInsider
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™
May 4, 2026 6:59 AM - BizWire
Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at BMO Capital
May 1, 2026 4:10 AM - StreetInsider
BofA: Bristol update may boost Cytokinetics shares
April 30, 2026 12:12 PM - StreetInsider
Form 10-Q BRISTOL MYERS SQUIBB CO For: Mar 31
April 30, 2026 11:45 AM - SEC Filing
Bristol-Myers Squibb trumps Q1 estimates, maintains full-year outlook
April 30, 2026 7:21 AM - StreetInsider
Bristol-Myers Squibb (BMY) Tops Q1 EPS by 16c; reaffirms guidance
April 30, 2026 7:03 AM - StreetInsider
Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 30
April 30, 2026 7:02 AM - SEC Filing
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
April 30, 2026 6:59 AM - BizWire
Form SCHEDULE 13G BRISTOL MYERS SQUIBB CO Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 5:09 PM - SEC Filing
Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs
April 24, 2026 6:59 AM - StreetInsider
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
April 24, 2026 6:59 AM - BizWire
Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb
April 23, 2026 8:01 AM - StreetInsider
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
April 23, 2026 8:00 AM - PR NewsWire
Full Article List
